Alembic Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Sep '24
Jun '24
Mar '24
Dec '23
Sep '23
Total Qtr Revenue cr
1,664.72
1,563.83
1,520.58
1,633.46
1,605.08
Other Income Qtr Cr16.742.103.602.8910.15
Operating Revenues Qtr1,647.981,561.731,516.981,630.571,594.93

*All values are in Cr.

Operating Expenses Qtr
1,408.71
1,324.90
1,256.92
1,364.21
1,386.69
Operating Profit Qtr
239.27
236.83
260.06
266.36
208.25
EBIDT Qtr Cr
268.88
238.93
263.66
269.25
218.40
Depreciation Qtr
70.51
69.04
69.48
69.45
67.56
Net Profit Qtr
153.40
134.71
178.21
180.45
136.56
Basic EPS Qtr
7.79
6.85
9.07
9.18
6.95
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -